Aboriginal and Torres Strait Islander people aged 2 months to 19 years are recommended to receive MenACWY vaccine

Aboriginal and Torres Strait Islander people aged 2 months to 19 years are recommended to receive MenACWY vaccine.

MenACWY vaccine is funded through the NIP for all children aged 12 months and all adolescents aged 14-16 years. For details see the National Immunisation Program Schedule.

The dose schedule for MenACWY vaccine depends on the vaccine brand and the person’s age when they start the vaccine course.

Aboriginal and Torres Strait Islander infants and children with specified medical risk conditions are recommended to receive an additional dose of MenACWY vaccine, see People with medical conditions that increase their risk of invasive meningococcal disease.

Infants aged <12 months can receive 2 of the 3 brands of MenACWY vaccine (Menveo or Nimenrix).

There is no preference for either brand of MenACWY vaccine – MenQuadfi, Menveo, or Nimenrix – for people aged ≥12 months.